EPSOM, England (October 02, 2009) – Thermo Fisher Scientific Inc., the world leader in serving science, has just published the latest edition of Insights, a quarterly newsletter focusing on the leading-edge genomic technologies available from Thermo Scientific Genomics. Insights provides life scientists with a mix of product application notes, user stories, latest product information and answers to frequently asked questions to assist them in their research.
Featured articles in the latest edition (Issue 23) include:
• Genome-scale RNAi screens at your benchtop - Decode RNAi Viral Screening Libraries
• Progressive solutions for advancing drug discovery and therapeutic development - RNAi Discovery and Therapeutic Services
• Optimized Quantitation of Marek's Disease Virus using Multiplex QPCR - ABsolute Blue & ABsolute Fast QPCR master mixes
• Successful siRNA Delivery into Primary Neuronal Cells - Accell siRNA reagents
• Robust Silencing Paired with Sensitive Detection as Part of an Optimized Gene Silencing System - ABsolute Blue & ABsolute Fast QPCR master mixes
To download a copy electronically or sign up to receive the newsletter as hard copy, please visit http://www.dharmacon.com/m360/ or talk to your local Thermo Scientific Genomics representative.
Thermo Scientific is part of Thermo Fisher Scientific Inc., the world leader in serving science.
Photograph attached, caption: The latest edition of Insights, from Thermo Scientific Genomics, provides life scientists with a mix of product application notes, user stories, product information and answers to frequently asked questions to assist them in their research.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With 2008 revenues of $10.5 billion, we have approximately 34,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.
Featured articles in the latest edition (Issue 23) include:
• Genome-scale RNAi screens at your benchtop - Decode RNAi Viral Screening Libraries
• Progressive solutions for advancing drug discovery and therapeutic development - RNAi Discovery and Therapeutic Services
• Optimized Quantitation of Marek's Disease Virus using Multiplex QPCR - ABsolute Blue & ABsolute Fast QPCR master mixes
• Successful siRNA Delivery into Primary Neuronal Cells - Accell siRNA reagents
• Robust Silencing Paired with Sensitive Detection as Part of an Optimized Gene Silencing System - ABsolute Blue & ABsolute Fast QPCR master mixes
To download a copy electronically or sign up to receive the newsletter as hard copy, please visit http://www.dharmacon.com/m360/ or talk to your local Thermo Scientific Genomics representative.
Thermo Scientific is part of Thermo Fisher Scientific Inc., the world leader in serving science.
Photograph attached, caption: The latest edition of Insights, from Thermo Scientific Genomics, provides life scientists with a mix of product application notes, user stories, product information and answers to frequently asked questions to assist them in their research.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With 2008 revenues of $10.5 billion, we have approximately 34,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.
